Autoimmune Blood Tests: Antibodies, Inflammation & Immune Markers
Autoimmune diseases occur when the immune system mistakenly attacks the body’s own healthy tissues. There are more than 80 recognised autoimmune conditions, and collectively they affect roughly 1 in 10 Australians — making them one of the most common chronic disease categories. Blood tests for autoantibodies, inflammation markers, and complement levels are essential for early detection, accurate diagnosis, and ongoing monitoring. Understanding your results can help you work more effectively with your doctor and take control of your health.
What Are Autoantibodies?
Your immune system normally produces antibodies to fight infections caused by bacteria, viruses, and other foreign invaders. In autoimmune disease, the immune system creates antibodies that mistakenly target the body’s own proteins — these are called autoantibodies. Different autoantibodies target different tissues, which is why specific antibody tests help pinpoint which autoimmune condition may be present.
Positive Does Not Always Mean Disease
A positive autoantibody test does not automatically mean you have an autoimmune disease. Low-titre antibodies (e.g., ANA at 1:80) are found in many healthy people, especially women over 40. Your doctor will always interpret results alongside your symptoms, physical examination, and other investigations before making a diagnosis.
Negative Does Not Always Exclude Disease
Some autoimmune conditions are “seronegative” — meaning standard antibody tests come back negative despite active disease. About 20–30% of rheumatoid arthritis is seronegative for both RF and anti-CCP. Clinical assessment, imaging, and repeat testing over time remain essential for diagnosis.
Autoimmune Marker Reference Ranges
Reference ranges may vary between laboratories depending on the assay used. The values below are based on RCPA guidelines and the most commonly used assays in Australian pathology labs. Always compare your results with the reference range printed on your report.
| Marker | Normal Range | Unit | Clinical Note |
|---|---|---|---|
Antinuclear Antibody (ANA) | Negative (< 1:80 titre) | Titre | Patterns include homogeneous, speckled, nucleolar, and centromere — each suggests different conditions. |
Rheumatoid Factor (RF) | < 14 IU/mL | IU/mL | Positive in ~70% of rheumatoid arthritis but also in infections, liver disease, and healthy elderly. |
Anti-Cyclic Citrullinated Peptide (Anti-CCP) | < 5 U/mL | U/mL | Most specific marker for rheumatoid arthritis (~95% specificity). Often positive years before symptoms. |
Anti-double-stranded DNA (Anti-dsDNA) | < 10 IU/mL | IU/mL | Highly specific for systemic lupus erythematosus (SLE). Levels often correlate with disease activity. |
Erythrocyte Sedimentation Rate (ESR) | < 20 mm/hr (women) / < 15 mm/hr (men) | mm/hr | Non-specific inflammation marker. Rises slowly over days. Affected by age, anaemia, and pregnancy. |
C-Reactive Protein (CRP) | < 5 mg/L (hs-CRP < 1 mg/L) | mg/L | Acute-phase reactant produced by the liver. Rises within hours and peaks at 48 hours. |
Complement C3 (C3) | 0.83 – 1.77 g/L | g/L | Low C3 in active lupus, glomerulonephritis, and immune complex diseases (consumed during inflammation). |
Complement C4 (C4) | 0.12 – 0.36 g/L | g/L | Low C4 suggests classical complement pathway activation. Often the first complement to drop in lupus flares. |
Anti-Thyroid Peroxidase (Anti-TPO) | < 35 IU/mL | IU/mL | Primary marker for Hashimoto’s thyroiditis and predictive of future thyroid failure. |
Extractable Nuclear Antigen Panel (Anti-ENA) | Negative | Qualitative | Includes anti-Sm, anti-RNP, anti-SSA/Ro, anti-SSB/La. Helps differentiate lupus, Sjögren’s, and mixed connective tissue disease. |
Common Autoimmune Conditions & Their Markers
Each autoimmune condition has a characteristic pattern of autoantibodies and inflammation markers. Understanding which markers are associated with which conditions helps explain why your doctor may order specific panels of tests rather than a single blood test.
Rheumatoid Arthritis
Chronic inflammatory arthritis targeting joint synovium. Anti-CCP is the most specific marker (~95%). RF is found in ~70% of patients but is less specific. CRP and ESR track disease activity and response to treatment.
Systemic Lupus Erythematosus (SLE)
Multi-system autoimmune disease affecting skin, joints, kidneys, and brain. ANA is positive in >95% of cases. Anti-dsDNA and low complement levels correlate with flares, particularly lupus nephritis.
Hashimoto’s Thyroiditis
The most common autoimmune condition in Australia. Anti-TPO antibodies destroy thyroid tissue over years, eventually causing hypothyroidism. High anti-TPO with normal TSH indicates early or subclinical disease.
Sjögren’s Syndrome
Attacks moisture-producing glands causing dry eyes and dry mouth. Anti-SSA (Ro) is positive in ~70% and anti-SSB (La) in ~40%. Can occur alone (primary) or alongside lupus or rheumatoid arthritis (secondary).
Coeliac Disease
Immune reaction to gluten damaging the small intestine. Anti-tissue transglutaminase (tTG) IgA is the first-line screening test. Anti-endomysial antibody (EMA) confirms the diagnosis. Must be eating gluten for valid results.
Type 1 Diabetes
Autoimmune destruction of pancreatic beta cells causing insulin deficiency. Multiple autoantibody positivity predicts progression. Anti-GAD can remain positive for decades and helps distinguish from Type 2 diabetes in adults.
Understanding False Positives
One of the biggest sources of anxiety for patients is receiving a positive autoantibody result that turns out to have no clinical significance. False positives are surprisingly common in autoimmune testing.
ANA Positive in Healthy People
Up to 15–20% of healthy women have a positive ANA at low titre (1:40 or 1:80). The prevalence increases with age, and a positive ANA alone, without symptoms, rarely indicates lupus or another connective tissue disease. Higher titres (1:320+) and specific patterns are more clinically meaningful.
Rheumatoid Factor in Non-RA Conditions
About 5% of the general healthy population test positive for RF. It is also found in chronic infections (hepatitis C, tuberculosis), liver cirrhosis, Sjögren’s syndrome, and even in heavy smokers. RF alone is insufficient to diagnose rheumatoid arthritis without supporting clinical findings.
Low-Titre ANA in the Elderly
ANA positivity at low titres becomes increasingly common with age. Up to 25–30% of people over 65 may have a positive ANA without any autoimmune disease. This is thought to reflect age-related immune dysregulation rather than true autoimmunity.
Transient Positivity After Infection
Viral infections, including Epstein-Barr virus (glandular fever), can trigger temporary autoantibody production that resolves within weeks to months. A single positive result during or shortly after illness should be confirmed with repeat testing 3–6 months later.
The Diagnostic Journey
Autoimmune diseases are among the most difficult conditions to diagnose because symptoms overlap between conditions, blood tests can be positive without disease, and disease can be present with negative tests. Diagnosis is rarely based on a single blood test — it requires the combination of clinical symptoms, physical examination findings, blood results, and often imaging studies.
Clinical Assessment
Your doctor evaluates your symptoms, family history, and physical findings. Joint swelling, rashes, dry eyes, and Raynaud’s phenomenon are all important clues that guide which tests to order.
Initial Screening Bloods
ANA, RF, CRP, and ESR are commonly ordered as a first-line screen. A positive ANA prompts further specific antibody testing (anti-dsDNA, ENA panel). Anti-CCP is ordered when RA is suspected.
Confirmatory Testing
Specific autoantibodies, complement levels, urinalysis, and imaging (X-ray, ultrasound, MRI) narrow the diagnosis. Some conditions require tissue biopsy (e.g., kidney biopsy for lupus nephritis, skin biopsy for vasculitis).
Specialist Referral
A rheumatologist, immunologist, or relevant specialist confirms the diagnosis and develops a treatment plan. Ongoing monitoring with regular blood tests tracks disease activity and medication effects.
Who Should Be Tested?
Autoimmune blood tests are not routine screening tests for healthy people. They are ordered when your doctor suspects an autoimmune condition based on your symptoms and clinical presentation. Consider asking your GP about autoimmune testing if you experience:
Key Symptoms Warranting Testing
Persistent joint pain, swelling, or morning stiffness lasting > 30 minutes
Unexplained skin rashes, particularly across cheeks and nose (butterfly rash)
Persistent dry eyes and dry mouth (sicca symptoms)
Raynaud’s phenomenon — fingers turning white or blue in cold
Recurrent miscarriage or unexplained blood clots
Unexplained hair loss, mouth ulcers, or photosensitivity
Risk Factors for Autoimmune Disease
Family history of autoimmune conditions (first-degree relatives)
Female sex — women are 3–9 times more likely for most autoimmune diseases
Personal history of one autoimmune condition (increases risk of developing another)
Recent viral infection (Epstein-Barr, COVID-19) with new persistent symptoms
Unexplained chronic fatigue with elevated CRP or ESR
Multiple symptoms affecting different organ systems simultaneously
Related Blood Test Guides
When to See Your Doctor Urgently
Early diagnosis and treatment of autoimmune diseases can prevent irreversible organ damage. If you have concerning symptoms, do not wait for them to resolve on their own.
Track Your Immune Markers Over Time
Upload your blood test results to see ANA, RF, complement levels, CRP, and other autoimmune markers trending on interactive charts. Spot flares early and share professional reports with your rheumatologist — free forever for the first million users.
Get Started FreeMedical Disclaimer: This guide is for educational purposes only and does not constitute medical advice. Autoimmune blood test results must always be interpreted by a qualified healthcare professional in the context of your symptoms, medical history, and other test results. A positive autoantibody test alone does not diagnose an autoimmune disease.